Innovations in Diagnosis and Treatment of Multiple Sclerosis

Medical Breakthroughs from Penn Medicine

Innehåll tillhandahållet av ReachMD. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av ReachMD eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

8+ y ago

MP3•Episod hem

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on January 10, 2024 12:11 (10M ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Host: Jennifer Caudle, DO
Guest: Joseph Berger, MD, FACP, FAAN, FANA
Multiple sclerosis is a notoriously difficult disease to diagnose early on. With no singular confirmatory tests yet available, physicians often become reluctant to identify MS in their patients, leading to years of diagnostic and treatment uncertainty. But new innovations are helping doctors establish earlier diagnoses and start more targeted treatments for MS patients. Dr. Jennifer Caudle welcomes Dr. Joseph Berger, Professor of Neurology at Penn Medicine, to explore some of these innovations advancing MS diagnosis and treatment.

114 episoder

#Science #Medicine #Breast Cancer #ReachMD #Health and Well-Being